authors
- Sobel, Burton E
- Ashok Krishnaswami, MD, MAS
- Frye, Robert L
- Hardison, Regina M
- Genuth, Saul
- Brooks, Maria M
- McBane, Robert D
- Schneider, David J
- Pratley, Richard E
- Huber, Kurt
- Wolk, Robert
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2011
published in
- Circulation Journal
has subject area
- Adult
- Biomarkers
- C-Reactive Protein
- Coronary Disease
- Diabetes Mellitus, Type 2
- Drug Therapy, Combination
- Female
- Fibrin Fibrinogen Degradation Products
- Fibrinogen
- Fibrinolysis
- Follow-Up Studies
- Glycated Hemoglobin
- Humans
- Hypoglycemic Agents
- Inflammation
- Insulin
- Insulin Resistance
- Kaplan-Meier Estimate
- Male
- Metformin
- Middle Aged
- Myocardial Revascularization
- Plasminogen Activator Inhibitor 1
- Prognosis
- Sulfonylurea Compounds
- Thiazolidinediones
- Thrombophilia
- Tissue Plasminogen Activator